10.51
전일 마감가:
$10.48
열려 있는:
$10.47
하루 거래량:
381.12K
Relative Volume:
0.52
시가총액:
$622.39M
수익:
$1.10B
순이익/손실:
$83.60M
주가수익비율:
7.3468
EPS:
1.43
순현금흐름:
$132.30M
1주 성능:
+5.05%
1개월 성능:
-15.21%
6개월 성능:
-22.98%
1년 성능:
-32.05%
Embecta Corp Stock (EMBC) Company Profile
명칭
Embecta Corp
전화
(862) 401-0000
주소
1209 ORANGE STREET, WILMINGTON
Compare EMBC vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
EMBC
Embecta Corp
|
10.51 | 620.62M | 1.10B | 83.60M | 132.30M | 1.43 |
|
ISRG
Intuitive Surgical Inc
|
498.08 | 177.84B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
182.45 | 51.97B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
82.78 | 40.42B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
47.41 | 39.70B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
256.41 | 37.72B | 5.40B | 1.49B | 1.78B | 10.12 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 개시 | Mizuho | Neutral |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-27 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-10-20 | 개시 | Wolfe Research | Peer Perform |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-09-08 | 개시 | BTIG Research | Neutral |
| 2022-08-01 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-06-21 | 개시 | BofA Securities | Underperform |
모두보기
Embecta Corp 주식(EMBC)의 최신 뉴스
Does Embecta Corp. have high return on assets2025 Volatility Report & Safe Swing Trade Setup Alerts - mfd.ru
Dow Update: Will BETR benefit from current market trendsJuly 2025 Opening Moves & Weekly Stock Breakout Alerts - baoquankhu1.vn
Embecta shareholders back board, pay, and equity plan - The Globe and Mail
Will Embecta Corp. stock gain from lower inflationPortfolio Performance Report & High Conviction Buy Zone Alerts - mfd.ru
Why analysts remain bullish on Embecta Corp. stockPortfolio Return Summary & Reliable Price Breakout Signals - mfd.ru
Embecta Corp. (EMBC) Investor Outlook: Exploring a 66.67% Upside Potential with a Robust Dividend Yield - DirectorsTalk Interviews
Embecta's (NASDAQ:EMBC) Solid Earnings Have Been Accounted For Conservatively - simplywall.st
Why Embecta's (NASDAQ:EMBC) Earnings Are Better Than They Seem - 富途牛牛
We Think Embecta's (NASDAQ:EMBC) Solid Earnings Are Understated - Yahoo Finance
Embecta names CEO Kurdikar as new board chair, picks new lead independent director - Drug Delivery Business
Embecta Corp. Appoints Devdatt Kurdikar as Chairman and Dr. Claire Pomeroy as Lead Independent Director - Quiver Quantitative
embecta names new Chairman of the Board and Lead Independent Director - The Manila Times
What’s the RSI of Embecta Corp. stock2025 Trade Ideas & AI Forecasted Entry and Exit Points - mfd.ru
Embecta (NASDAQ:EMBC) Is Paying Out A Dividend Of $0.15 - Yahoo Finance
Embecta outlines $1.71B–$1.93B revenue target for 2026 as GLP-1 partnerships gain traction - MSN
Can Embecta Corp. stock surprise with earnings upside2025 Stock Rankings & Low Risk High Reward Trade Ideas - mfd.ru
Embecta Announces Board Changes, Effective February 11, 2026 - marketscreener.com
Embecta (NASDAQ:EMBC) Trading Down 5%Should You Sell? - MarketBeat
Earnings Beat: Embecta Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - simplywall.st
Embecta Corp. Just Recorded A 28% EPS Beat: Here's What Analysts Are Forecasting Next - 富途牛牛
Trading the Move, Not the Narrative: (EMBC) Edition - Stock Traders Daily
Embecta (NASDAQ:EMBC) Will Pay A Dividend Of $0.15 - simplywall.st
Embecta Earnings Call: U.S. Headwinds, Global Offsets - TipRanks
Embecta (NASDAQ:EMBC) Downgraded to Buy Rating by Wall Street Zen - MarketBeat
3 Healthcare Stocks Paying the Highest Dividends of 2026 - The Motley Fool
Embecta: Stable Execution, GLP-1–Driven Growth Optionality, and Attractive Valuation Support Buy Rating and $25 Target - TipRanks
BTIG Research Reiterates "Buy" Rating for Embecta (NASDAQ:EMBC) - MarketBeat
Embecta Corp. (NASDAQ:EMBC) Q1 2026 Earnings Call Transcript - Insider Monkey
BTIG Reiterates Buy Rating on Embecta (EMBC) with Stable Price T - GuruFocus
Embecta Q1 2026 slides: Beats EPS estimates as international growth offsets U.S. decline By Investing.com - Investing.com South Africa
Embecta (EMBC) Margin Rebound And 4.4x P E Challenge Cautious Narratives - simplywall.st
Embecta Q1 2026 slides: Beats EPS estimates as international growth offsets U.S. decline - Investing.com Nigeria
Embecta Corp. (NASDAQ:EMBC) to Issue $0.15 Quarterly Dividend - MarketBeat
Embecta Q1 Earnings Call Highlights - MarketBeat
Embecta Corp (EMBC) Q1 2026 Earnings Call Highlights: Strategic Progress Amidst Market Challenges By GuruFocus - Investing.com Canada
Embecta reports Q1 adjusted EPS 71c, consensus 67c - TipRanks
Embecta (NASDAQ:EMBC) Releases Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat
Embecta Q1 2026 Earnings Call Transcript - MarketBeat
Embecta Corp. SEC 10-Q Report - TradingView
Revenue Check: What is the PEG ratio of Embecta CorpQuarterly Risk Review & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Embecta (NASDAQ:EMBC) Shares Gap Up on Better-Than-Expected Earnings - MarketBeat
Embecta stock ticks up on Street-beating Q1 - Drug Delivery Business
Embecta (EMBC) Q1 2026 Earnings Call Transcript - The Globe and Mail
Earnings call transcript: Embecta Q1 2026 beats earnings estimates, stock rises - Investing.com Nigeria
EMBC: Q1 revenue met expectations; U.S. headwinds offset by international growth and GLP-1 progress - TradingView
Embecta (NASDAQ:EMBC) Issues FY 2026 Earnings Guidance - MarketBeat
Embecta earnings beat by $0.04, revenue topped estimates - Investing.com
Embecta Corp (NASDAQ:EMBC) Stock Falls 6.5% on Q1 Revenue Miss Despite EPS Beat - ChartMill
Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results - TradingView
EMBECTA ($EMBC) Releases Q1 2026 Earnings - Quiver Quantitative
Embecta Q1 Earnings Summary & Key Takeaways - Benzinga
Embecta Corp (EMBC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):